Literature DB >> 26777402

Bile Duct Injury after Irreversible Electroporation of Hepatic Malignancies: Evaluation of MR Imaging Findings and Laboratory Values.

Marco Dollinger, Florian Zeman, Christoph Niessen, Sven A Lang, Lukas P Beyer, Martina Müller, Christian Stroszczynski, Philipp Wiggermann.   

Abstract

PURPOSE: To evaluate biliary complications after irreversible electroporation (IRE) of hepatic malignancies.
MATERIALS AND METHODS: In 24 patients (17 men; mean age, 59.3 y), bile ducts were located within a 1.0-cm radius of the ablation zone at subacute follow-up (ie, 1–3 d) after percutaneous IRE of 53 hepatic tumors (primary hepatic tumors, n = 14). MR imaging, conducted with a hepatocyte-specific contrast agent before and after treatment, was examined for evidence of bile duct injury. Serum bilirubin and alkaline phosphatase levels measured at subacute and short-term follow-up (ie, 1–2 mo after IRE) were analyzed for evidence of biliary injury. Correlations between bile duct injury and characteristics of patients, lesions, and ablation procedures were assessed by generalized linear models.
RESULTS: Fifty-five bile ducts were located within 1.0 cm of an ablation defect. Locations relative to the ablation area were as follows: 33 were encased, 14 were abutting, and 8 were located within a radius of 0.1–1.0 cm of the ablation zone. Subacute follow-up MR images showed 15 bile duct injuries (narrowing, n = 8; dilation, n = 7). At subacute follow-up, three patients showed transient abnormalities of laboratory values (bilirubin, 1.6–5.2 mg/dL). Short-term laboratory values were abnormal in one patient (increase in alkaline phosphatase of 533 U/L vs baseline) as a result of local tumor recurrence. Patient age (continuous, P = .026; < 65 y vs ≥ 65 y, P = .001) was independently associated with post-IRE bile duct injury.
CONCLUSIONS: Bile ducts adjacent to an IRE ablation area remain largely unaffected by this procedure.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26777402     DOI: 10.1016/j.jvir.2015.10.002

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  19 in total

1.  Preclinical and clinical evaluation of the liver tumor irreversible electroporation by magnetic resonance imaging.

Authors:  Matteo Figini; Xifu Wang; Tianchu Lyu; Zhanliang Su; Daniele Procissi; Vahid Yaghmai; Andrew C Larson; Zhuoli Zhang
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

2.  Transmural ablation of the normal porcine common bile duct with catheter-directed irreversible electroporation is feasible and does not affect duct patency.

Authors:  Eisuke Ueshima; Mark Schattner; Robin Mendelsohn; Hans Gerdes; Sebastien Monette; Haruyuki Takaki; Jeremy C Durack; Stephen B Solomon; Govindarajan Srimathveeravalli
Journal:  Gastrointest Endosc       Date:  2017-05-10       Impact factor: 9.427

Review 3.  Modern therapeutic approaches for the treatment of malignant liver tumours.

Authors:  Henrik Petrowsky; Ralph Fritsch; Matthias Guckenberger; Michelle L De Oliveira; Philipp Dutkowski; Pierre-Alain Clavien
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-07-17       Impact factor: 46.802

Review 4.  Individualized Ablation of Hepatocellular Carcinoma: Tailored Approaches across the Phenotype Spectrum.

Authors:  Zlatko Devcic; Mohamed Elboraey; Lucas Vidal; Kabir Mody; Denise Harnois; Tushar Patel; Beau B Toskich
Journal:  Semin Intervent Radiol       Date:  2019-10-31       Impact factor: 1.513

5.  Irreversible electroporation of malignant liver tumors: Effect on laboratory values.

Authors:  Mohammed Alnaggar; Ammar M Qaid; Jibing Chen; Lizhi Niu; Kecheng Xu
Journal:  Oncol Lett       Date:  2018-07-02       Impact factor: 2.967

6.  Early assessment of irreversible electroporation ablation outcomes by analyzing MRI texture: preclinical study in an animal model of liver tumor.

Authors:  Aydin Eresen; Kang Zhou; Chong Sun; Junjie Shangguan; Bin Wang; Liang Pan; Su Hu; Yongsheng Pang; Zigeng Zhang; Robert Minh Nhat Tran; Ajeet Pal Bhatia; Farouk Nouizi; Nadine Abi-Jaoudeh; Vahid Yaghmai; Zhuoli Zhang
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

7.  Peri-tumoral Metallic Implants Reduce the Efficacy of Irreversible Electroporation for the Ablation of Colorectal Liver Metastases.

Authors:  Francois H Cornelis; Helena Cindrič; Bor Kos; Masashi Fujimori; Elena N Petre; Damijan Miklavčič; Stephen B Solomon; Govindarajan Srimathveeravalli
Journal:  Cardiovasc Intervent Radiol       Date:  2019-08-05       Impact factor: 2.740

Review 8.  Imaging after percutaneous thermal and non-thermal ablation of hepatic tumour: normal appearances, progression and complications.

Authors:  Germain Bréhier; Louis Besnier; Anaïs Delagnes; Frédéric Oberti; Jérôme Lebigot; Christophe Aubé; Anita Paisant
Journal:  Br J Radiol       Date:  2021-04-01       Impact factor: 3.629

9.  Intraprocedural Transcatheter Intraarterial Perfusion (TRIP)-MRI for Evaluation of Irreversible Electroporation Therapy Response in a Rabbit Liver Tumor Model.

Authors:  Anna J Shangguan; Kang Zhou; Jia Yang; Aydin Eresen; Bin Wang; Chong Sun; Liang Pan; Su Hu; Ali T Khan; Samdeep K Mouli; Vahid Yaghmai; Zhuoli Zhang
Journal:  Clin Exp Gastroenterol       Date:  2020-11-06

10.  Focused Transhepatic Electroporation Mediated by Hypersaline Infusion through the Portal Vein in Rat Model. Preliminary Results on Differential Conductivity.

Authors:  Clara Pañella; Quim Castellví; Xavier Moll; Rita Quesada; Alberto Villanueva; Mar Iglesias; Dolores Naranjo; Patricia Sánchez-Velázquez; Anna Andaluz; Luís Grande; Antoni Ivorra; Fernando Burdío
Journal:  Radiol Oncol       Date:  2017-11-29       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.